Business ❯ Corporate Strategy

Research and Development

Innovation Investment Product Development Market Expansion Cost Management Product Innovation Partnerships Capital Expenditure Manufacturing Product Pipeline

Zhongji Announces Up to ¥8 Billion A‑Share Buyback Ahead of Hong Kong IPO

The company said the repurchase is meant to steady mainland share prices so the Hong Kong listing does not open below its IPO offer price.

Stories older than 24h

GSK Reports Q2 Beat and Unveils £1.9 Billion Savings Plan

Alphabet Raises 2026 AI CapEx to $195–$205 Billion as Cloud Revenue Soars

Samsung Creates CEO‑Led RX Division to Centralize Robotics Push

XPeng Begins Closed Beta of Factory-Built GX Robotaxi

Apple’s Plan for a Cheaper Vision Pro Loses a Key Display Partner

Solstice to Buy Element Solutions in $14.5 Billion Deal

BTQ Technologies Wins Approval to Buy French Quantum Firm QPerfect

Momenta Launches Hong Kong IPO Seeking HK$5.89 Billion

UK Clears Oral Wegovy and Foundation Pledges Europe Research Cash

SpaceX Lists on Nasdaq as Falcon 9 Rockets Deliver More Starlink Satellites

Chinese Auto and Tech Firms Push Back on Viral Robot and New‑Brand Claims

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

Semtech Shares Surge After Strong Q1 Results and Bullish Q2 Guidance

Regeneron Strikes Parabilis Deal to Develop Antibody-Helicon Drugs

Broadcom Shares Fall After Trump‑Xi Talks Leave China Chip Shipments Unclear

Moderna Jumps on Hantavirus Cruise-Ship Cluster as U.S. Repatriates 17 Citizens

L&T Launches Industrial Electronics Unit, Commissions Coimbatore Lines

TSMC Sets 2029 Targets for A13 and A12, Delaying High‑NA EUV

Lam Research Beats Q3 and Raises Outlook as Analysts Lift Targets